Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients

P. Bernasconi, P. M. Cavigliano, M. Boni, S. Calatroni, C. Klersy, I. Giardini, B. Rocca, N. Crosetto, M. Caresana, M. Lazzarino, C. Bernasconi

Research output: Contribution to journalArticle

Abstract

Conventional cytogenetics (CC) at clinical diagnosis shows a normal karyotype in 40-60% of de novo myelodysplastic syndromes (MDSs). Fluorescence in situ hybridization (FISH) might detect occult aberrations in these patients. Therefore, we have used FISH to check 57 MDS patients who were karyotypically normal on CC. At clinical diagnosis, FISH revealed a clonal abnormality in 18-28% interphase cells from nine patients, five of whom also presented the same defect on metaphase FISH. In five out of nine patients, the occult defect effected a change in the international prognostic scoring system (IPSS). An abnormal FISH pattern was significantly correlated with marrow blast cell percentage (P-3) and IPSS (P-3). Patients with an occult abnormality showed an overall survival and event-free survival significantly inferior in comparison to those of patients with normal FISH (P-3, P-3). Death and AML progression were 15- and eight-fold more frequent in FISH abnormal patients. In conclusion, occult defects (1) are revealed in about 15% of CC normal MDS patients, (2) are overlooked by CC either because of the poor quality of metaphases or their submicroscopic nature, (3) are clinically relevant as they may cause a change in the IPSS category and may identify a fraction of CC normal patients with an unfavorable clinical outcome.

Original languageEnglish
Pages (from-to)2107-2112
Number of pages6
JournalLeukemia
Volume17
Issue number11
DOIs
Publication statusPublished - Nov 2003

Fingerprint

Myelodysplastic Syndromes
Fluorescence In Situ Hybridization
Cytogenetics
Chromosomes
Metaphase
Interphase
Karyotype
Disease-Free Survival
Bone Marrow
Survival

Keywords

  • Chromosome abnormalities
  • Conventional cytogenetics
  • FISH
  • IPSS

ASJC Scopus subject areas

  • Cancer Research
  • Hematology

Cite this

Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients. / Bernasconi, P.; Cavigliano, P. M.; Boni, M.; Calatroni, S.; Klersy, C.; Giardini, I.; Rocca, B.; Crosetto, N.; Caresana, M.; Lazzarino, M.; Bernasconi, C.

In: Leukemia, Vol. 17, No. 11, 11.2003, p. 2107-2112.

Research output: Contribution to journalArticle

Bernasconi, P. ; Cavigliano, P. M. ; Boni, M. ; Calatroni, S. ; Klersy, C. ; Giardini, I. ; Rocca, B. ; Crosetto, N. ; Caresana, M. ; Lazzarino, M. ; Bernasconi, C. / Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients. In: Leukemia. 2003 ; Vol. 17, No. 11. pp. 2107-2112.
@article{681e5c0a06604539a7509beb3c62fb1b,
title = "Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients",
abstract = "Conventional cytogenetics (CC) at clinical diagnosis shows a normal karyotype in 40-60{\%} of de novo myelodysplastic syndromes (MDSs). Fluorescence in situ hybridization (FISH) might detect occult aberrations in these patients. Therefore, we have used FISH to check 57 MDS patients who were karyotypically normal on CC. At clinical diagnosis, FISH revealed a clonal abnormality in 18-28{\%} interphase cells from nine patients, five of whom also presented the same defect on metaphase FISH. In five out of nine patients, the occult defect effected a change in the international prognostic scoring system (IPSS). An abnormal FISH pattern was significantly correlated with marrow blast cell percentage (P-3) and IPSS (P-3). Patients with an occult abnormality showed an overall survival and event-free survival significantly inferior in comparison to those of patients with normal FISH (P-3, P-3). Death and AML progression were 15- and eight-fold more frequent in FISH abnormal patients. In conclusion, occult defects (1) are revealed in about 15{\%} of CC normal MDS patients, (2) are overlooked by CC either because of the poor quality of metaphases or their submicroscopic nature, (3) are clinically relevant as they may cause a change in the IPSS category and may identify a fraction of CC normal patients with an unfavorable clinical outcome.",
keywords = "Chromosome abnormalities, Conventional cytogenetics, FISH, IPSS",
author = "P. Bernasconi and Cavigliano, {P. M.} and M. Boni and S. Calatroni and C. Klersy and I. Giardini and B. Rocca and N. Crosetto and M. Caresana and M. Lazzarino and C. Bernasconi",
year = "2003",
month = "11",
doi = "10.1038/sj.leu.2403108",
language = "English",
volume = "17",
pages = "2107--2112",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients

AU - Bernasconi, P.

AU - Cavigliano, P. M.

AU - Boni, M.

AU - Calatroni, S.

AU - Klersy, C.

AU - Giardini, I.

AU - Rocca, B.

AU - Crosetto, N.

AU - Caresana, M.

AU - Lazzarino, M.

AU - Bernasconi, C.

PY - 2003/11

Y1 - 2003/11

N2 - Conventional cytogenetics (CC) at clinical diagnosis shows a normal karyotype in 40-60% of de novo myelodysplastic syndromes (MDSs). Fluorescence in situ hybridization (FISH) might detect occult aberrations in these patients. Therefore, we have used FISH to check 57 MDS patients who were karyotypically normal on CC. At clinical diagnosis, FISH revealed a clonal abnormality in 18-28% interphase cells from nine patients, five of whom also presented the same defect on metaphase FISH. In five out of nine patients, the occult defect effected a change in the international prognostic scoring system (IPSS). An abnormal FISH pattern was significantly correlated with marrow blast cell percentage (P-3) and IPSS (P-3). Patients with an occult abnormality showed an overall survival and event-free survival significantly inferior in comparison to those of patients with normal FISH (P-3, P-3). Death and AML progression were 15- and eight-fold more frequent in FISH abnormal patients. In conclusion, occult defects (1) are revealed in about 15% of CC normal MDS patients, (2) are overlooked by CC either because of the poor quality of metaphases or their submicroscopic nature, (3) are clinically relevant as they may cause a change in the IPSS category and may identify a fraction of CC normal patients with an unfavorable clinical outcome.

AB - Conventional cytogenetics (CC) at clinical diagnosis shows a normal karyotype in 40-60% of de novo myelodysplastic syndromes (MDSs). Fluorescence in situ hybridization (FISH) might detect occult aberrations in these patients. Therefore, we have used FISH to check 57 MDS patients who were karyotypically normal on CC. At clinical diagnosis, FISH revealed a clonal abnormality in 18-28% interphase cells from nine patients, five of whom also presented the same defect on metaphase FISH. In five out of nine patients, the occult defect effected a change in the international prognostic scoring system (IPSS). An abnormal FISH pattern was significantly correlated with marrow blast cell percentage (P-3) and IPSS (P-3). Patients with an occult abnormality showed an overall survival and event-free survival significantly inferior in comparison to those of patients with normal FISH (P-3, P-3). Death and AML progression were 15- and eight-fold more frequent in FISH abnormal patients. In conclusion, occult defects (1) are revealed in about 15% of CC normal MDS patients, (2) are overlooked by CC either because of the poor quality of metaphases or their submicroscopic nature, (3) are clinically relevant as they may cause a change in the IPSS category and may identify a fraction of CC normal patients with an unfavorable clinical outcome.

KW - Chromosome abnormalities

KW - Conventional cytogenetics

KW - FISH

KW - IPSS

UR - http://www.scopus.com/inward/record.url?scp=10744227653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744227653&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2403108

DO - 10.1038/sj.leu.2403108

M3 - Article

C2 - 12931223

AN - SCOPUS:10744227653

VL - 17

SP - 2107

EP - 2112

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 11

ER -